文献速递消化道肿瘤与早癌

11q23.1 遗传变异通过失调结肠簇细胞转录激活因子 POU2AF2 赋予结直肠癌风险

Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2.
PubMed 文献 · Gut · 2025-04-07

研究采用 RNA 测序、单细胞 RNA 测序、染色质免疫沉淀测序和单细胞 ATAC 测序,确定 rs3087967 为 11q23.1 主要 eQTL 变异并与结直肠癌风险共定位;该变异影响 21 个远处基因表达,作为簇细胞标记基因集的 trans-eQTL 枢纽;免疫荧光证实风险基因型 T 与人类结肠簇细胞减少相关;小鼠种系 CRISPR 缺失风险位点基因在 Pou2af2 表达消失时加重 ApcMin/+ 表型。

要点

  • rs3087967 是 11q23.1 主要 eQTL 变异,与结直肠癌风险共定位。
  • rs3087967 风险基因型 T 与人类结肠簇细胞减少相关。
  • POU2AF2 是簇细胞主要转录激活因子,小鼠模型中具抑癌作用。

核心结论

  • rs3087967 基因型通过错误调控 POU2AF2 控制一组基因;POU2AF2 是簇细胞主要转录激活因子,在小鼠模型中具抑癌作用;簇细胞在大肠上皮中具有关键肿瘤保护作用。

研究设计与样本

  • 研究分析 RNA 测序、单细胞 RNA 测序、染色质免疫沉淀测序和单细胞 ATAC 测序数据,识别、优先排序并表征贡献结直肠癌风险的基因;进一步用小鼠模型验证,并展示人类结肠黏膜中的平行效应。

主要发现

  • 确立 rs3087967 为 11q23.1 主要 eQTL 变异,与结直肠癌风险共定位。
  • rs3087967 影响 21 个远处基因表达,作为高度富集簇细胞标记基因集的 trans-eQTL 枢纽。
  • 表观基因组分析提示 POU2AF2 通过 POU2F3 相关基因组调控控制簇细胞特异性 trans 基因。
  • 免疫荧光证实 rs3087967 风险基因型 T 与人类结肠簇细胞减少相关。
  • 小鼠种系 CRISPR 缺失 11q23.1 风险位点基因,在 Pou2af2 表达特异消失时加重 ApcMin/+ 小鼠表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Common genetic variation at 11q23.1 is associated with colorectal cancer (CRC) risk, exerting local expression quantitative trait locus (cis-eQTL) effects on POU2AF2, COLCA1 and POU2AF3 genes. However, complex linkage disequilibrium and correlated expression has hindered elucidation of the mechanisms by which genetic variants impart underlying CRC risk. OBJECTIVE: Undertake an interdisciplinary approach to understand how variation at 11q23.1 locus imparts CRC risk. DESIGN: We employ analysis of RNA sequencing, single-cell RNA sequencing, chromatin immunoprecipitation sequencing and single-cell ATAC sequencing data to identify, prioritise and characterise the genes that contribute to CRC risk. We further validate these findings using mouse models and demonstrate parallel effects in human colonic mucosa. RESULTS: We establish rs3087967 as a prime eQTL variant at 11q23.1, colocalising with CRC risk. Furthermore, rs3087967 influences expression of 21 distant genes, thereby acting as a trans-eQTL hub for a gene-set highly enriched for tuft cell markers. Epigenomic analysis implicates POU2AF2 as controlling the tuft cell-specific trans-genes, through POU2F3-correlated genomic regulation. Immunofluorescence confirms rs3087967 risk genotype (T) to be associated with a tuft cell deficit in the human colon. CRISPR-mediated deletion of the 11q23.1 risk locus genes in the mouse germline exacerbated the ApcMin/+ mouse phenotype on abrogation of Pou2af2 expression specifically. CONCLUSION: We demonstrate that genotype at rs3087967 controls a portfolio of genes through misregulation of POU2AF2. POU2AF2 is the primary transcriptional activator of tuft cells with a tumour suppressive role in mouse models. We therefore implicate tuft cells as having a key tumour-protective role in the large bowel epithelium.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Rajasekaran V, Harris BT, Osborn RT, et al. Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2. Gut. 2025. PMID: 39609081. doi:10.1136/gutjnl-2024-332121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。